Pharmafile Logo

OTC Awards

- PMLiVE

Life sciences reimagined

Reassessing future priorities in the wake of the pandemic

- PMLiVE

Paris Court of Appeal overturns Novartis and Roche’s €444m anti-competitiveness fine

It was questioned whether the companies had used their market power to boost sales of their eye disease drug

- PMLiVE

BMS reports positive three-year results for Opdivo to treat bladder cancer

Urothelial carcinoma accounts for approximately 90% of bladder cancer cases

- PMLiVE

NICE publishes final draft guidance recommending three COVID-19 treatments

The medicines have shown promise in treating COVID-19 and been found cost-effective

- PMLiVE

Gilead’s Trodelvy shows promise in phase 2 bladder cancer study

An estimated 83,000 Americans will be diagnosed with bladder cancer in 2023

- PMLiVE

Pro bono publico

Seven key principles for success for pro bono working

- PMLiVE

FDA external report recommends actions to address US opioid crisis

Over 100,000 Americans died from a drug overdose in 2021, with 70,000 of those due to opioids

- PMLiVE

Merck reports positive results for Keytruda combination in phase 3 gastric cancer trial

Over one million new cases of gastric cancer were diagnosed globally in 2020

- PMLiVE

Gates MRI and Calibr announce licensing agreement for tuberculosis treatment

TB is a severe disease responsible for an estimated 1.5 million deaths per year

- PMLiVE

Results for GSK’s RSV vaccine candidate published in New England Journal of Medicine

RSV infections in older adults account for around 6,000 to 10,000 deaths in the US each year

- PMLiVE

LifeArc’s challenge to combat bronchiectasis

PME talks to Catherine Kettleborough about the charity’s new £100m programme to fast-track scientific discoveries into new healthcare solutions

Origins’ Strategy Offering Explained

What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy...

Origins – The Patient Focused Specialists

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links